RETINAL DISEASE

This study tests an experimental drug called VP-001 for people with a rare inherited eye disease that causes vision loss (retinitis pigmentosa linked to the PRPF31 gene). The drug is injected into the eye and aims to slow or stop further vision decline. Sixteen adults who have al…

This study tests a drug called ultevursen for people with retinitis pigmentosa caused by changes in the USH2A gene. The drug is injected into the eye and may help slow the loss of vision over two years. About 81 adults and children ages 8 and older will take part.

This pilot study tests a new handheld device that automatically aligns to take detailed pictures of the retina (the back of the eye). Researchers will scan healthy adult volunteers and patients (adults and children) in eye clinics to see if the device works well. The goal is to i…

This study looks at blood flow in the back of the eye in people with pseudoxanthoma elasticum (PXE), a rare genetic disease that can cause vision loss. Researchers will compare eye scans from 60 participants — half with PXE and half healthy — to see if reduced blood flow can serv…

This study tests a new imaging tool that gives surgeons a live, 3D view inside the eye during surgery. It includes up to 262 people with various eye conditions like retinal detachment, cataracts, or macular holes, as well as healthy volunteers. The goal is to see if this technolo…